Literature DB >> 17239356

Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users.

Derik Hermann1, Alexander Sartorius, Helga Welzel, Sigrid Walter, Gisela Skopp, Gabriele Ende, Karl Mann.   

Abstract

BACKGROUND: Cannabinoids present neurotoxic and neuroprotective properties in in vitro studies, inconsistent alterations in human neuroimaging studies, neuropsychological deficits, and an increased risk for psychotic episodes.
METHODS: Proton magnetic resonance spectroscopy ((1)H-MRS), neuropsychological testing, and hair analysis for cannabinoids was performed in 13 male nontreatment-seeking recreational cannabis users and 13 male control subjects.
RESULTS: A significantly diminished N-acetylaspartate/total creatine (NAA/tCr) ratio in the dorsolateral prefrontal cortex (DLPFC) was observed in cannabis users (p = .0003). The NAA/tCr in the putamen/globus pallidum region correlated significantly with cannabidiol (R(2) = .66, p = .004). Results of the Wisconsin Card Sorting test, Trail making Test, and D2 test for attention were influenced by cannabinoids.
CONCLUSIONS: Chronic recreational cannabis use is associated with an indication of diminished neuronal and axonal integrity in the DLPFC in this study. As chronic cannabis use is a risk factor for psychosis, these results are interesting because diminished NAA/tCr ratios in the DLPFC and neuropsychological deficits were also reported in schizophrenia. The strong positive correlation of NAA/tCr and cannabidiol in the putamen/globus pallidum is in line with neuroprotective properties of cannabidiol, which were also observed in in vitro model studies of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17239356     DOI: 10.1016/j.biopsych.2006.08.027

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  48 in total

Review 1.  Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.

Authors:  Marc W Manseau; Donald C Goff
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors.

Authors:  Hanna J Szkudlarek; Sagar J Desai; Justine Renard; Brian Pereira; Christopher Norris; Christina E L Jobson; Nagalingam Rajakumar; Brian L Allman; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2018-11-27       Impact factor: 7.853

Review 3.  HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

Authors:  Bianca Cotto; Kalimuthusamy Natarajanseenivasan; Dianne Langford
Journal:  Prog Neurobiol       Date:  2019-05-18       Impact factor: 11.685

Review 4.  An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions.

Authors:  Rebecca D Crean; Natania A Crane; Barbara J Mason
Journal:  J Addict Med       Date:  2011-03       Impact factor: 3.702

Review 5.  Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Authors:  Stephanie C Licata; Perry F Renshaw
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

6.  Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability.

Authors:  William S John; Thomas J Martin; Kiran Kumar Solingapuram Sai; Susan H Nader; H Donald Gage; Akiva Mintz; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2017-12-04       Impact factor: 4.030

7.  Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study.

Authors:  Andrew P Prescot; Allison E Locatelli; Perry F Renshaw; Deborah A Yurgelun-Todd
Journal:  Neuroimage       Date:  2011-02-22       Impact factor: 6.556

8.  γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers.

Authors:  Andrew P Prescot; Perry F Renshaw; Deborah A Yurgelun-Todd
Journal:  Drug Alcohol Depend       Date:  2013-03-21       Impact factor: 4.492

Review 9.  The Impact of Marijuana Use on Memory in HIV-Infected Patients: A Comprehensive Review of the HIV and Marijuana Literatures.

Authors:  Linda M Skalski; Sheri L Towe; Kathleen J Sikkema; Christina S Meade
Journal:  Curr Drug Abuse Rev       Date:  2016

10.  Altered subjective reward valuation among drug-deprived heavy marijuana users: Aversion to uncertainty.

Authors:  Kathryn R Hefner; Mark J Starr; John J Curtin
Journal:  J Abnorm Psychol       Date:  2015-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.